文献速递临床生化质量管理与危急值

LDL-C计算公式依赖的阈值分类差异与报告不确定性:UK Biobank分析

Formula-dependent LDL-C threshold classification and reporting uncertainty in the UK Biobank.
PubMed 文献 · Clin Chem Lab Med · 2026-09-11

在UK Biobank 397,490名参与者中,比较Friedewald、Sampson-NIH和Martin-Hopkins公式估算LDL-C与直接LDL-C在2.60 mmol/L阈值处的分类差异。总不一致率分别为5.96%、3.91%和3.23%,随甘油三酯升高而增加,尤其在2.26-4.51 mmol/L区间Friedewald公式差异最大。不一致低值组甘油三酯、BMI、糖尿病患病率和降脂药使用更高,但apoB和非HDL-C更低,不支持二元阈值不一致作为稳定不良预后标志。

要点

  • LDL-C公式选择影响近2.60 mmol/L阈值的分类,甘油三酯越高差异越大。
  • Friedewald公式在甘油三酯2.26-4.51 mmol/L时负偏差和不一致低值频率最大。
  • 计算LDL-C应视为有公式相关不确定性的估计值,可辅以非HDL-C和apoB。

核心结论

  • LDL-C公式选择影响阈值分类,尤其在富含甘油三酯样本接近2.60 mmol/L时。
  • 计算LDL-C在决策阈值附近应视为带有公式相关不确定性的估计值。
  • 非HDL-C及可用的apoB可提供补充信息。

研究设计与样本

  • 基于UK Biobank的分析,经质量控制排除及排除缺失直接LDL-C或甘油三酯≥4.52 mmol/L者后,纳入397,490名参与者。
  • 比较Friedewald、Sampson-NIH和Martin-Hopkins估算值与UK Biobank直接LDL-C参照,在2.60 mmol/L方法比较阈值处评估。
  • 分析包括阈值不一致、甘油三酯分层、apoB/非HDL-C表型、阈值窗口敏感性分析及较窄ASCVD终点。

主要发现

  • 总阈值不一致率:Friedewald 5.96%,Sampson-NIH 3.91%,Martin-Hopkins 3.23%。
  • 不一致率随甘油三酯升高而增加。
  • 在甘油三酯2.26-4.51 mmol/L区间,Friedewald负差值最大(中位差-0.379 mmol/L;不一致低值频率12.9%),Martin-Hopkins差异较小(中位差-0.119 mmol/L;4.3%)。
  • 广泛心血管复合终点和较窄ASCVD终点模型不支持二元阈值不一致作为稳定不良预后标志。
  • 不一致低值参与者甘油三酯、BMI、糖尿病患病率和降脂药使用更高,但apoB和非HDL-C更低。

关键数值与推荐

  • 方法比较阈值:2.60 mmol/L(100 mg/dL)。
  • 甘油三酯排除阈值:≥4.52 mmol/L(≥400 mg/dL)。
  • 甘油三酯分层区间:2.26-4.51 mmol/L(200-399 mg/dL)。

临床怎么用

  • 在决策阈值附近解读计算LDL-C时,应考虑公式相关的不确定性。
  • 对富含甘油三酯样本,可结合非HDL-C和apoB(若可用)进行补充评估。
  • 公式选择可能影响阈值分类,报告时应明确所用公式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Calculated low-density lipoprotein cholesterol (LDL-C) is widely reported, but formula-dependent estimation differences may alter classification near decision thresholds. We assessed formula-dependent LDL-C classification relative to direct LDL-C in UK Biobank and examined cardiovascular outcomes descriptively. METHODS: We analyzed 397,490 participants after quality-control exclusions and exclusion of those with missing direct LDL-C or triglycerides ≥4.52 mmol/L (≥400 mg/dL). Friedewald, Sampson-NIH, and Martin-Hopkins estimates were compared with the UK Biobank direct LDL-C comparator at a 2.60 mmol/L (100 mg/dL) method-comparison threshold. Analyses assessed threshold discordance, triglyceride strata, apolipoprotein B (apoB)/non-high-density lipoprotein cholesterol (non-HDL-C) phenotypes, threshold-window sensitivity analyses, and narrower atherosclerotic cardiovascular disease (ASCVD) endpoints. RESULTS: Total threshold discordance was 5.96 % for Friedewald, 3.91 % for Sampson-NIH, and 3.23 % for Martin-Hopkins. Discordance increased with triglycerides. At 2.26-4.51 mmol/L (200-399 mg/dL), Friedewald had the largest negative calculated-minus-comparator difference and discordant low frequency (median difference -0.379 mmol/L; 12.9 %), whereas Martin-Hopkins had smaller differences (median -0.119 mmol/L; 4.3 %). Broad cardiovascular composite and narrower ASCVD endpoint models did not support binary threshold discordance as a stable adverse prognostic marker. Discordant low participants had higher triglycerides, body mass index (BMI), diabetes prevalence, and cholesterol-lowering medication use, but lower apoB and non-HDL-C. CONCLUSIONS: LDL-C formula selection affected classification, especially in triglyceride-rich samples near 2.60 mmol/L (100 mg/dL). Calculated LDL-C may warrant interpretation as an estimate with formula-related uncertainty near decision thresholds; non-HDL-C and, where available, apoB may provide complementary information.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Xue B, Ma T, Shen C, et al. Formula-dependent LDL-C threshold classification and reporting uncertainty in the UK Biobank. Clin Chem Lab Med. 2026. PMID: 42721054. doi:10.1515/cclm-2026-0687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。